课题基金 / 基金详情

Development of a humanised antibody for treatment of cancer and stroke

Development of a humanised antibody for treatment of cancer and stroke
开发用于治疗癌症和中风的人源化抗体
批准号:
nhmrc : 1075898
负责人:
Prof Andrew Scott
金额:
$16.19万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Development Grants
财政年份:
2014
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2014-01-01 至 2014-12-31

项目摘要

项目成果

Prof Andrew Scott的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This grant explores the ability of novel monoclonal antibodies to inhibit cancer cell growth, and to prevent complications in patients with brain injuries. The results of this work will enable the development of new strategies for antibody-based therapy of many types of cancer, and improve outcomes in patients suffering from acute stroke.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developmental Therapeutics for the Treatment of Gastrointestinal Cancers
  • 批准号:
    nhmrc : GNT1092788
  • 项目类别:
    Programs
  • 资助金额:
    $521.54万
  • 财政年份:
    2016
  • 负责人:
    Prof Andrew Scott
  • 依托单位:
Developmental Therapeutics for the Treatment of Gastrointestinal Cancers
  • 批准号:
    nhmrc : 1092788
  • 项目类别:
    Program Grants
  • 资助金额:
    $359.58万
  • 财政年份:
    2016
  • 负责人:
    Prof Andrew Scott
  • 依托单位:
Molecular Imaging and Therapy of Cancer
  • 批准号:
    nhmrc : GNT1084178
  • 项目类别:
    Practitioner Fellowships
  • 资助金额:
    $47.27万
  • 财政年份:
    2015
  • 负责人:
    Prof Andrew Scott
  • 依托单位:
Molecular Imaging and Therapy of Cancer
  • 批准号:
    nhmrc : 1084178
  • 项目类别:
    Practitioner Fellowships
  • 资助金额:
    $32.9万
  • 财政年份:
    2015
  • 负责人:
    Prof Andrew Scott
  • 依托单位:
海外基金